SFX by Ex Libris Inc.

Title:	Discovery of 5-Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119
Source:	Journal of Medicinal Chemistry [0022-2623] Wacker, Dean yr:2014

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wang, M. "The first radiosynthesis of [11C]AZD8931 as a new potential PET agent for imaging of EGFR, HER2 and HER3 signaling." Bioorganic and medicinal chemistry letters 24.18 (2014): 4455-4459.
description	2.	Mahmood, U. "An EGFR Targeted PET Imaging Probe for the Detection of Colonic Adenocarcinomas in the Setting of Colitis." Theranostics 4.9 (2014): 893-903.
description	3.	Qian, J. "A novel approach for the synthesis of Crizotinib through the key chiral alcohol intermediate by asymmetric hydrogenation using highly active Ir-Spiro-PAP catalyst." Tetrahedron letters 55.9 (2014): 1528-1531.
description	4.	Wang, Q. "Synthesis of carbon-11-labeled 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine derivatives as new potential PET tracers for imaging of p38Î± mitogen-activated protein kinase." Bioorganic and medicinal chemistry letters 24.16 (2014): 3700-3705.
description	5.	Juvale, K. "Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2)." Bioorganic & medicinal chemistry 21.24 (2013): 7858-7873.
description	6.	Harris, Craig S. "Facile synthesis of 7-amino anilinoquinazolines via direct amination of the quinazoline core." Tetrahedron letters 46.43 (2005): 7381-7384.
description	7.	Petrulli, Joseph R. "Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domain." Neoplasia 15.12 (2013): 1347-53.
description	8.	Tabor, V. "MYC Synergizes with Activated BRAFV600E in Mouse Lung Tumor Development by Suppressing Senescence." Cancer research 74.16 (2014): 4222-4229.
description	9.	Zhou, Q. "Carboxy-directed asymmetric hydrogenation of alpha-alkyl-alpha-aryl terminal olefins: highly enantioselective and chemoselective access to a chiral benzylmethyl center." Organic & biomolecular chemistry 12.13 (2014): 2049-2052.
description	10.	Peng, Z. "Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level." Bioorganic & medicinal chemistry 22.1 (2014): 623-632.
description	11.	Kar, S. "Study of the nano-morphological versatility by self-assembly of a peptide mimetic molecule in response to physical and chemical stimuli." Chemical communications (London. 1996) 50.20 (2014): 2638-2641.
description	12.	Larsen, Matthew A. "Iridium-Catalyzed C–H Borylation of Heteroarenes: Scope, Regioselectivity, Application to Late-Stage Functionalization, and Mechanism." Journal of the American Chemical Society 136.11 (2014): 4294967295-4299.
description	13.	Lin, J. "Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: Dual inhibitors of EGFR and Src protein tyrosine kinases." European journal of medicinal chemistry 55 (2012): 39-48.
description	14.	Campa, D. "Interactions Between Genetic Variants and Breast Cancer Risk Factors in the Breast and Prostate Cancer Cohort Consortium." Journal of the National Cancer Institute 103.16 (2011): 1252-1263.
description	15.	Mueller, Jaime A. "Origin of Enantioselection in Chiral Alcohol Oxidation Catalyzed by Pd[(-)-sparteine]Cl2." Journal of the American Chemical Society 127.42 (2005): 14817-14824.
description	16.	Woodburn, J R R. "The epidermal growth factor receptor and its inhibition in cancer therapy." Pharmacology & therapeutics 82.2-3 (1999): 241-250.
description	17.	Buckley, George M. "IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding." Bioorganic & medicinal chemistry letters 18.11 (2008): 3291-.
description	18.	Wang, J. "Synthesis of [11C]iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase." Bioorganic & medicinal chemistry letters 16.15 (2006): 4102-6.
description	19.	Ray, Nicholas C. "Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators." Bioorganic & medicinal chemistry letters 17.17 (2007): 4901-5212.
description	20.	Hosoda, S. "Ligands with dual vitamin D3-agonistic and androgen-antagonistic activities." Bioorganic & medicinal chemistry letters 15.19 (2005): 4327-4331.